Toggle menu
+44 20 3393 8531

Mouse Anti-Human Neuroblastoma mAb | Gentaur

€340.00
(No reviews yet) Write a Review
SKU:
544-MBS370092-GEN
Availability:
IN STOCK
Size:
100 µg
Adding to cart… category.add_cart_announcement

Product Description

Mouse Anti-Human Neuroblastoma mAb

Monoclonal antibodies (mAbs) are part of the standard of care for the treatment of many adult solid tumors. Until recently none have been approved for use in children with solid tumors. Neuroblastoma (NB) is the most common extracranial solid tumor in children. Those with high-risk disease, despite treatment with very intensive multimodal therapy, still have poor overall survival.

Results of treatment with an immunotherapy regimen using a chimeric (human/mouse) mAb against a cell surface disialoganglioside (GD2) have changed the standard of care for these children and resulted in the first approval of a mAb for use in children with solid tumors.

This article will review the use of the various anti-GD2 mAbs in children with NB, methods that have been or are being evaluated for enhancing their efficacy, as well as review other promising antigenic targets for the therapeutic use of mAbs in children with NB.

Keywords: immunotherapy, neuroblastoma, anti-disialoganglioside, anti-GD2, chimeric, effector cells.

Product Videos

Custom Field

Size 100 µg

Product Reviews

Write a Review